BY Advocate.com Editors
August 30 2002 12:00 AM ET
Cancer drug shows promise in treating K.S.
Phase II human trials of Bristol-Myers Squibb's anticancer drug paclitaxel--already approved to treat some cases of breast, ovarian, and lung cancers under the brand name Taxol--have shown that the drug is effective in treating advanced AIDS-related Kaposi's sarcoma, AIDS Policy & Law reports. The medication appears most useful in treating K.S. in patients who have failed other chemotherapy agents. The drug was evaluated in 107 male patients with advanced K.S. who had failed at least one previous regimen of systemic chemotherapy. More than half of the patients experienced a complete or partial response to the drug. Additional data from the clinical trial is expected to be released later this year. Phase III trials are planned.
- Meet the 2013 Point Foundation Scholars
- Republican Wants Right to Fire LGBT Employees Who 'Work in a Tutu'
- Sen. Lisa Murkowski Endorses Marriage Equality
- WATCH: Trans Woman Attacked in Hollywood Hate Crime Speaks Out, Cops Offer Reward
- Op-ed: How Animated Shows Like Futurama Can Unite Us All
- WATCH: Gay Marine Proposes to Boyfriend
Sign Up For Email Updates
- Women WATCH: Hot Lesbians Don Cowboy Hats, Chaps and Spurs for Cowgirl Up 9 min 30 sec ago
- Pride PHOTOS: Marry Me in Maine 25 min ago
- World News Brazil Lawmakers Legalize 'Ex-Gay' Therapy 29 min 1 sec ago
- Marriage Equality Florida Group Aims to Build Marriage Equality Support 1 hour 24 min ago
- Women WATCH: The L Word's Kate Moennig in Ray Donovan Series Premiere 1 hour 28 min ago
- Crime Man Pleads Not Guilty to West Village Murder 1 hour 36 min ago
- Crime WATCH: Trans Woman Attacked in Hollywood Hate Crime Speaks Out 1 hour 51 min ago